Related Content

• Conditions (12): Achalasia, Myasthenia Gravis, Parkinson's Disease, and 9 others Achalasia, Myasthenia Gravis, Parkinson's Disease, Peptic Ulcer, Genetic and Rare Conditions, Intestinal Obstruction, Bladder neck obstruction, Abnormalities, Drug-Induced, Gastrointestinal Diseases, Esophageal Diseases, Multiple Sclerosis, skin hypersensitivity [hide]
• Groups (3): Achalasia, Myasthenia Gravis, Parkinson's Disease Achalasia, Myasthenia Gravis, Parkinson's Disease [hide]
• Symptoms (8): Hypersensitivity, Pupillary Dilation function, Decreased Respiratory Secretions, and 5 others Hypersensitivity, Pupillary Dilation function, Decreased Respiratory Secretions, Positive Chronotropy, Salivation Inhibition, Achalasia, Immediate hypersensitivity, Myasthenia Gravis [hide]
• Treatments (26): Benztropine 1 MG Oral Tablet, Scopolamine, Benztropine 1 MG/ML Injectable Solution, and 23 others Benztropine 1 MG Oral Tablet, Scopolamine, Benztropine 1 MG/ML Injectable Solution, BENZTROPINE MESYLATE 1 MG, URINARY ANTISEPTIC W/METHENAMINE 40.8MG TAB, URINARY ANTISEPTIC W/METHENAMINE 120MG TAB, Trihexyphenidyl Hydrochloride, Benztropine 0.5 MG Oral Tablet, URINARY ANTISEPTIC W/METHENAMINE 40.8MG/GELSEMIUM/AZOPHEN TAB, Scopolamine 0.4 MG/ML Injectable Solution, Trihexyphenidyl 2 MG Oral Tablet, Benztropine, Benztropine 2 MG Oral Tablet, URINARY ANTISEPTIC W/METHENAMINE 40.8MG/GELSEMIUM TAB, Belladonna Alkaloids 0.13 MG / Phenobarbital 16.2 MG Oral Capsule, 24 HR Scopolamine 0.0138 MG/HR Transdermal Patch, BELLADONNA ALKALOIDS 0.1296MG/SIMETHICONE 40MG LIQUID,ORAL, BENZTROPINE MESYLATE 0.5 MG, URISAL TAB, HYOSCINE HYDROBROMIDE 0.0065 MG/30ML, SCOPOLAMINE HYDROBROMIDE 0.003 MG, BENZTROPINE MESYLATE 1 MG/ML, BENZTROPINE MESYLATE 2 MG, Belladonna Alkaloids 0.203 MG Oral Tablet, Belladonna Alkaloids 0.026 MG/ML / Phenobarbital 3.24 MG/ML Elixir, Belladonna Alkaloids 16.2 MG / Opium 30 MG Rectal Suppository [hide]

About Benzatropine Methanesulfonate

A synthetic antiparkinson tertiary amine structurally related to atropine, Benztropine Mesylate acts as a central muscarinic antagonist and inhibits dopamine uptake. With antihistaminic and local anesthetic properties as well, it is indicated for symptomatic relief of parkinsonism and drug-induced... more

A synthetic antiparkinson tertiary amine structurally related to atropine, Benztropine Mesylate acts as a central muscarinic antagonist and inhibits dopamine uptake. With antihistaminic and local anesthetic properties as well, it is indicated for symptomatic relief of parkinsonism and drug-induced extrapyramidal reactions. (NCI04)

less